GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million

TAIPEI and SAN DIEGO, July 14, 2026 /PRNewswire/ — GEM Global Yield LLC SCS (“GEM”) has executed a Share Purchase Agreement (the “SPA”) with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc. (TPEx: 6492), under which GEM has committed up to NT$500 million (approximately…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks